These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 22286763)

  • 1. Estrogenic regulation of S6K1 expression creates a positive regulatory loop in control of breast cancer cell proliferation.
    Maruani DM; Spiegel TN; Harris EN; Shachter AS; Unger HA; Herrero-González S; Holz MK
    Oncogene; 2012 Dec; 31(49):5073-80. PubMed ID: 22286763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S6 kinase 1 regulates estrogen receptor alpha in control of breast cancer cell proliferation.
    Yamnik RL; Digilova A; Davis DC; Brodt ZN; Murphy CJ; Holz MK
    J Biol Chem; 2009 Mar; 284(10):6361-9. PubMed ID: 19112174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The IGF pathway regulates ERα through a S6K1-dependent mechanism in breast cancer cells.
    Becker MA; Ibrahim YH; Cui X; Lee AV; Yee D
    Mol Endocrinol; 2011 Mar; 25(3):516-28. PubMed ID: 21292829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of S6K1 in ER-positive breast cancer.
    Holz MK
    Cell Cycle; 2012 Sep; 11(17):3159-65. PubMed ID: 22895181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. mTORC1 directly phosphorylates and activates ERα upon estrogen stimulation.
    Alayev A; Salamon RS; Berger SM; Schwartz NS; Cuesta R; Snyder RB; Holz MK
    Oncogene; 2016 Jul; 35(27):3535-43. PubMed ID: 26522726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PI3K/mTOR mediate mitogen-dependent HDAC1 phosphorylation in breast cancer: a novel regulation of estrogen receptor expression.
    Citro S; Miccolo C; Meloni L; Chiocca S
    J Mol Cell Biol; 2015 Apr; 7(2):132-42. PubMed ID: 25801958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ERα-miR-575-p27 feedback loop regulates tamoxifen sensitivity in ER-positive Breast Cancer.
    Liu SS; Li Y; Zhang H; Zhang D; Zhang XB; Wang X; Yu Y
    Theranostics; 2020; 10(23):10729-10742. PubMed ID: 32929377
    [No Abstract]   [Full Text] [Related]  

  • 8. Wilms' tumor 1 suppressor gene mediates antiestrogen resistance via down-regulation of estrogen receptor-alpha expression in breast cancer cells.
    Han Y; Yang L; Suarez-Saiz F; San-Marina S; Cui J; Minden MD
    Mol Cancer Res; 2008 Aug; 6(8):1347-55. PubMed ID: 18708366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein kinase A exhibits selective modulation of estradiol-dependent transcription in breast cancer cells that is associated with decreased ligand binding, altered estrogen receptor alpha promoter interaction, and changes in receptor phosphorylation.
    Al-Dhaheri MH; Rowan BG
    Mol Endocrinol; 2007 Feb; 21(2):439-56. PubMed ID: 17068199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FOXC1 is involved in ERα silencing by counteracting GATA3 binding and is implicated in endocrine resistance.
    Yu-Rice Y; Jin Y; Han B; Qu Y; Johnson J; Watanabe T; Cheng L; Deng N; Tanaka H; Gao B; Liu Z; Sun Z; Bose S; Giuliano AE; Cui X
    Oncogene; 2016 Oct; 35(41):5400-5411. PubMed ID: 27041579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
    Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
    Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular reprogramming by the conjoint action of ERα, FOXA1, and GATA3 to a ligand-inducible growth state.
    Kong SL; Li G; Loh SL; Sung WK; Liu ET
    Mol Syst Biol; 2011 Aug; 7():526. PubMed ID: 21878914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Williams syndrome transcription factor (WSTF) acts as an activator of estrogen receptor signaling in breast cancer cells and the effect can be abrogated by 1α,25-dihydroxyvitamin D
    Lundqvist J; Kirkegaard T; Laenkholm AV; Duun-Henriksen AK; Bak M; Feldman D; Lykkesfeldt AE
    J Steroid Biochem Mol Biol; 2018 Mar; 177():171-178. PubMed ID: 28610873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unraveling the regulatory connections between two controllers of breast cancer cell fate.
    Lee J; Tiwari A; Shum V; Mills GB; Mancini MA; Igoshin OA; Balázsi G
    Nucleic Acids Res; 2014 Jun; 42(11):6839-49. PubMed ID: 24792166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signal transducer and activator of transcription 5b, c-Src, and epidermal growth factor receptor signaling play integral roles in estrogen-stimulated proliferation of estrogen receptor-positive breast cancer cells.
    Fox EM; Bernaciak TM; Wen J; Weaver AM; Shupnik MA; Silva CM
    Mol Endocrinol; 2008 Aug; 22(8):1781-96. PubMed ID: 18550772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AKT3 regulates ErbB2, ErbB3 and estrogen receptor α expression and contributes to endocrine therapy resistance of ErbB2(+) breast tumor cells from Balb-neuT mice.
    Grabinski N; Möllmann K; Milde-Langosch K; Müller V; Schumacher U; Brandt B; Pantel K; Jücker M
    Cell Signal; 2014 May; 26(5):1021-9. PubMed ID: 24463007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The G protein-coupled receptor GPR30 inhibits proliferation of estrogen receptor-positive breast cancer cells.
    Ariazi EA; Brailoiu E; Yerrum S; Shupp HA; Slifker MJ; Cunliffe HE; Black MA; Donato AL; Arterburn JB; Oprea TI; Prossnitz ER; Dun NJ; Jordan VC
    Cancer Res; 2010 Feb; 70(3):1184-94. PubMed ID: 20086172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Menin, a product of the MENI gene, binds to estrogen receptor to enhance its activity in breast cancer cells: possibility of a novel predictive factor for tamoxifen resistance.
    Imachi H; Murao K; Dobashi H; Bhuyan MM; Cao X; Kontani K; Niki S; Murazawa C; Nakajima H; Kohno N; Yamashita H; Iwase H; Hayashi S; Ishida T; Yamauchi A
    Breast Cancer Res Treat; 2010 Jul; 122(2):395-407. PubMed ID: 19847644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen-induced aurora kinase-A (AURKA) gene expression is activated by GATA-3 in estrogen receptor-positive breast cancer cells.
    Jiang S; Katayama H; Wang J; Li SA; Hong Y; Radvanyi L; Li JJ; Sen S
    Horm Cancer; 2010 Feb; 1(1):11-20. PubMed ID: 21761347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of estrogen receptor antagonism toward p53 and its implications in breast cancer therapeutic response and stem cell regulation.
    Konduri SD; Medisetty R; Liu W; Kaipparettu BA; Srivastava P; Brauch H; Fritz P; Swetzig WM; Gardner AE; Khan SA; Das GM
    Proc Natl Acad Sci U S A; 2010 Aug; 107(34):15081-6. PubMed ID: 20696891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.